You might also like

Availability alert

More about Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology

• Book details
• Synopsis
• Trending among others

You get 281 loyalty points

Book synopsis

Anemia is a frequent complication of cancer and its treatment. It produces many symptoms and significantly impairs metabolic and physiologic functions as well as patients' activity, well-being and quality of life. Life expectancy is also affected. This book, now being published in its second edition, comprehensively presents the current knowledge on anemia in cancer and its treatment with rhEPO. Future developments are also discussed. Based on updated and new chapters, including a broader spectrum of topics, outstanding international experts describe the scientific and clinical aspects of anemia in various fields of oncology and give diagnostic and therapeutic recommendations on when and how to use rhEPO. The book, considered as a standard work, will again serve as an essential source of information for radiotherapists, medical oncologists, hematologists, internists, pediatricians, surgeons, specialists in transfusion and laboratory medicine, and pharmacologists.

Book details

Book category Books in English Medicine Clinical & internal medicine Diseases & disorders

• Full title: Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology
• Subtitle: Scientific and Clinical Aspects of Anemia in Cancer
• Author: Mohammad R. Nowrousian
• Language: English
• Binding: Hardback
• Number of pages: 866
• EAN: 9783211252239
• ISBN: 3211252231
• ID: 05265853
• Publisher: Springer Verlag GmbH
• Weight: 1718 g
• Dimensions: 244 × 170 × 50 mm
• Date of publishing: 19. December 2007

Trending among others

---

---

---